9/12/2013 9:56:46 AM
FLORENCE, Italy--(BUSINESS WIRE)--The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced it has acquired Silicon Biosystems, S.p.A., a provider of specialized molecular and cellular biology technologies capable of recovering and analyzing tumor cells from blood samples. Silicon Biosystems’ DEPArray™ and Ampli1™ genomic analysis technologies are being used in clinical research to advance the development of cancer diagnostics and accelerate the age of precision medicine through personalized therapies. Financial terms of the acquisition were not disclosed.
Help employers find you! Check out all the jobs and post your resume.
comments powered by